市场调查报告书
商品编码
1423760
到 2030 年基因表现分析市场预测:按产品、技术、应用、最终用户和地区进行的全球分析Gene Expression Analysis Market Forecasts to 2030 - Global Analysis By Product (DNA Chips, Kits & Reagents, Services and Other Products), Technology, Application, End User and By Geography |
根据Stratistics MRC预测,2023年全球基因表现分析市场规模将达49亿美元,预计2030年将达到100亿美元,预测期内复合年增长率为10.8%。
基因表现分析是指基因转录为RNA并翻译为蛋白质的过程,或对基因编码的功能产物的研究。测量特定条件下特定细胞、组织和生物体中基因的活性。基因表现分析有助于了解各种生物过程的分子机制,包括发育、分化、对刺激的反应和疾病。透过检查基因表现模式,研究人员可以识别参与特定途径的关键基因,揭示基因的调节方式,并深入了解疾病的分子基础。
印度工商联合会(FICCI)2016年的一项调查显示,印度生物技术领域近80%的科学家拥有博士学位或博士后学位,而20%拥有硕士学位。生产人员短缺18%。
扩大个人化医疗的采用
个人化医疗的采用正在迅速增加,重点是根据个人的基因谱量身订做治疗方法。这一趋势是由基因组研究和技术的进步所推动的,这些进步使得更准确地分析基因表现模式成为可能。随着医疗保健提供者意识到个人化方法的价值,市场预计将进一步扩大并为客製化治疗和诊断提供创新解决方案。
缺乏训练有素的专业人员
对基因表现资料解释和分析的熟练专业人员的需求远远超过目前的劳动力供应。这一不足对充分发挥基因组学在理解疾病和开发标靶治疗的潜力提出了重大挑战。透过教育和培训计划来弥补这一差距对于推动该领域发展并释放基因表现分析在医疗保健和生命科学领域的变革力量至关重要。市场面临训练有素的专业人员严重短缺,阻碍了基因组研究和诊断的进步。
快速的技术进步
高通量测序、单细胞分析和基因表现了前所未有的精确度和效率水平。基因表现分析技术的不断进步具有推进精准医学和改变我们对基因调控的理解的巨大潜力。市场正在见证快速的技术进步,彻底改变了对细胞功能的理解。
设备高成本
基因表现分析所需的先进技术和专业设备导致其价格高昂。这种经济障碍会限制小型实验室和研究机构充分从事综合基因表现研究的能力,影响该领域科学进步的整体性和进度。解决成本问题对于促进基因表现分析研究的广泛参与和创新至关重要。设备高成本是抑制市场成长的因素。
COVID-19 的疫情对市场产生了重大影响。随着人们对阐明病毒分子机制的兴趣不断增加,对基因表现分析工具的需求也随之增加。然而,供应链中断、实验室关闭和研究经费减少都是挑战。随着重点转向感染疾病研究,市场经历了高峰和下滑。对于该行业的公司来说,实现远端工作和数位解决方案已成为应对不确定性并保持发展势头的关键。
聚合酶炼式反应 (PCR) 领域预计将成为预测期内最大的领域
聚合酶炼式反应(PCR)部分预计将在预测期内成为最大的部分。这允许扩增特定 DNA 序列并促进灵敏且准确的基因表现分析。对个人化医疗的需求不断增长以及基因组学的进步正在促进市场扩张。主要企业正在投资创新的 PCR 技术来增强产品系列。由于PCR在诊断、治疗和研究活动中的应用不断扩大,预计该市场将继续成长。
药物研发和开发领域预计在预测期内复合年增长率最高
预计药物研发和开发领域在预测期内将出现最高的复合年增长率。研究人员利用尖端技术分析基因表现模式,以确定潜在的药物研发标靶和生物标记。这种复杂的方法可以更深入地了解疾病机制并有助于开发创新疗法。随着基因组学和生物资讯学的不断进步,这个市场对于塑造精准医疗和个人化治疗策略的未来仍然至关重要。
预计北美在预测期内将占据最大的市场占有率。该地区对基因表现工具(包括微阵列和次世代定序平台)的需求强劲。市场成长的关键因素包括基因组学研究活动的增加、慢性病盛行率的上升以及支持性的法规环境。研究机构和产业参与者之间的合作正在进一步推动基因表现分析的创新并确保繁荣的市场形势。
由于学术机构和生物技术公司之间的合作,预计亚太地区在预测期内将保持最高的复合年增长率。该地区的主要参与者正在积极开发基因表现分析的创新解决方案,为形成充满活力和竞争的形势做出贡献。随着该地区成为基因组和分子生物学研究的重要中心,市场的上升趋势预计将持续。
According to Stratistics MRC, the Global Gene Expression Analysis Market is accounted for $4.9 billion in 2023 and is expected to reach $10.0 billion by 2030 growing at a CAGR of 10.8% during the forecast period. Gene expression analysis refers to the study of the way genes are transcribed into RNA and translated into proteins, or the functional products they encode. It involves the measurement of the activity of genes in a particular cell, tissue, or organism under specific conditions. The analysis provides insights into wh Gene expression analysis for understanding the molecular mechanisms underlying various biological processes, including development, differentiation, response to stimuli, and diseases. By examining the patterns of gene expression, researchers can identify key genes involved in specific pathways, determine how genes are regulated, and gain insights into the molecular basis of diseases.
According to a 2016 survey conducted by the Federation of Indian Chambers of Commerce & Industry (FICCI), India faces an acute shortage of nearly 80% of Doctorate and Post Doctorate Scientists, a 20% shortage of people with a Master's degree, and a production staff shortage of 18% in the biotechnology sector.
Growing adoption of personalized medicine
The market is witnessing a surge in the adoption of personalized medicine, with a growing emphasis on tailoring treatments based on individual genetic profiles. This trend is driven by advancements in genomic research and technology, allowing for more precise analysis of gene expression patterns. As healthcare providers increasingly recognize the value of personalized approaches, the market is expected to expand further, offering innovative solutions for tailored therapies and diagnostics.
Shortage of trained professionals
The demand for skilled experts in interpreting and analyzing gene expression data far exceeds the current workforce supply. This shortage poses a significant challenge to harnessing the full potential of genomics in understanding diseases and developing targeted therapies. Addressing this gap through education and training initiatives is crucial to propel the field forward and unlock the transformative capabilities of gene expression analysis in healthcare and life sciences. The market faces a critical shortage of trained professionals, hindering advancements in genomic research and diagnostics.
Rapid technological advancement
Innovations in high-throughput sequencing, single-cell analysis, and bioinformatics have propelled gene expression analysis to unprecedented levels of accuracy and efficiency. The continuous evolution of gene expression analysis technologies holds immense promise for advancing precision medicine and transforming our understanding of genetic regulation. The market has witnessed rapid technological advancement, revolutionizing the understanding of cellular function.
High cost of the instruments
The sophisticated technology and specialized equipment required for gene expression analysis contribute to the elevated prices. This financial barrier may limit smaller laboratories or research facilities from fully engaging in comprehensive gene expression studies, potentially impacting the inclusivity and progress of scientific advancements in this field. Addressing cost concerns is crucial for fostering broader participation and innovation in gene expression analysis research. High cost of instruments is the factor hindering the growth of the market.
The COVID-19 pandemic has significantly impacted the market. Increased focus on understanding the virus's molecular mechanisms has driven demand for gene expression analysis tools. However, disruptions in supply chains, laboratory closures, and reduced funding for research have posed challenges. The market has witnessed both surges and declines, with shifts in priorities towards infectious disease research. Adapting to remote work and digital solutions has become crucial for companies in this sector to navigate the uncertainties and maintain momentum.
The polymerase chain reaction (PCR) segment is expected to be the largest during the forecast period
The polymerase chain reaction (PCR) segment is expected to be the largest during the forecast period. This enables amplification of specific DNA sequences, facilitating gene expression analysis with high sensitivity and precision. Increasing demand for personalized medicine and advancements in genomics contribute to market expansion. Key players are investing in innovative PCR technologies, enhancing product portfolios. The market is poised for continuous growth, propelled by the expanding applications of PCR in diagnostics, therapeutics, and research endeavors.
The drug discovery & development segment is expected to have the highest CAGR during the forecast period
The drug discovery & development segment is expected to have the highest CAGR during the forecast period. Leveraging cutting-edge technologies, researchers analyze gene expression patterns to identify potential drug targets and biomarkers. This sophisticated approach enables a deeper understanding of disease mechanisms, aiding in the development of innovative therapeutics. With continuous advancements in genomics and bioinformatics, the market remains integral to shaping the future of precision medicine and personalized treatment strategies.
North America is projected to hold the largest market share during the forecast period. The region showcases a strong demand for gene expression profiling tools, including microarrays and next-generation sequencing platforms. Key factors contributing to market growth include increasing research activities in genomics, rising prevalence of chronic diseases, and a supportive regulatory environment. Collaborations between research institutions and industry players further propel innovation in gene expression analysis, ensuring a flourishing market landscape.
Asia Pacific is projected to hold the highest CAGR over the forecast period owing to the collaborations between academic institutions and biotechnology companies. . Key players in the region are actively developing innovative solutions for gene expression analysis, contributing to a dynamic and competitive landscape. The market's upward trajectory is expected to continue as the region becomes a prominent hub for genomics and molecular biology research.
Key players in the market
Some of the key players in Gene Expression Analysis market include Agilent Technologies, GE Healthcare, Illumina, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd., Luminex Corp., Quest Diagnostics, Inc., PerkinElmer, Inc., Takara Bio, Inc., Catalent Inc., Promega Corp., Danaher Corp., QIAGEN, Novogene Corporation and Oxford Nanopore Technologies.
In August 2023, The MinION MK1C, a new sequencer designed to be more reasonably priced and available to researchers, has been launched, according to an announcement from Oxford Nanopore Technologies. Gene expression analysis and RNA and DNA sequencing can both be done using the MinION MK1C.
In January 2023, The bioinformatics division of QIAGEN, QIAGEN Digital Insights (QDI), has just launched the QIAGEN CLC Genomics Workbench Premium, which eliminates the data-analysis bottleneck of next-generation sequencing.